Pharmaceuticals

Study: New Bird Flu Resistant to Roche’s Tamiflu

Physicians in China have noted that some patients with bird flu are not responding to treatment with Tamiflu, the only known drug used to fight the infection. More 

AstraZeneca to Purchase Omthera

AstraZeneca will purchase Omertha, a make of fish-oil based pharmaceuticals as it continues to bolster its cardiovascular product lineup More 

New Obesity Drug Could Launch in U.S. Before 2015

Danish drug-maker Novo Nordisk says its anti-obesity treatment liraglutide could become available for sale in the U.S. by the end of 2014. More 

2 Stocks to Buy, 2 to Sell in Big Pharma

Big Pharma's on a roll these days along with the larger healthcare sector. With that in mind, here are two stocks to buy and two to sell in leading industries. More 

New Asthma Drug Could Be Game Changer

An asthma drug developed by Sanofi and Regeneron reduced asthma attacks by 87% in a mid-stage drug trial. More 

1 Stock to Buy, 1 Stock to Short: Small-Cap Pharma

The charts are showing an intermediate-term buy and a short-term shorting opportunity in these small-cap pharmaceutical stocks. More 

Should I Buy Pfizer? 3 Pros, 3 Cons

Pfizer's Q4 earnings put a small scare into investors a couple weeks back, but the pharma behemoth is built too well to ignore. More